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Abstract
Coronary artery disease (CAD) is a leading cause of death worldwide, despite improvements in me-
dical and interventional therapies. Based on many studies in large cohorts, regular physical exercise 
training plays a central and indispensable role in both the primary and secondary prevention of 
CAD. Exercise training was shown to improve blood pressure control, lipid profile, glucose con-
trol, and enhance weight loss in obese patients. Moreover, exercise training not only affects clinical 
symptoms, it reduces CAD mortality and morbidity in addition to dietary, pharmacological and 
interventional treatments. Different kinds of exercise training (aerobic, interval, resistance training) 
have been studied and all are feasible, well tolerated, and beneficial in patients with CAD. Therefore, 
exercise training has the highest recommendation class (I) and level of evidence (A) in the European 
guidelines for patients with coronary artery disease. Nonetheless, exercise training is underutilized 
in patients with cardiac diseases and only a minority of eligible patients is referred to a cardiac reha-
bilitation or structured exercise training program by their physician.
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Introduction
Coronary artery disease (CAD) is still a main cause of mortality worldwide. Based on many large 
cohort studies physical exercise training (ET) plays a central and indispensable role in both the primary 
and secondary prevention of CAD. Therefore, ET was given the highest recommendation class (I) and 
level of evidence (A) in the European guidelines for that issue [1]. However, despite the proven effects 
of ET, physical activity and structured exercise is underutilized in patients with CAD and only a mino-
rity of eligible patients are referred to a cardiac rehabilitation or ET program [2].
In this review, we describe effects of ET on CAD risk factors, impact on CAD morbidity and mortality, 
provide information about underlying mechanisms and discuss different kinds of ET.
Impact of ET on CAD risk factors
CAD results from atherosclerosis, with endothelial dysfunction as an early step in its development [3]. 
Several risk factors are well established to be associated with endothelial dysfunction and coronary 
artery disease (Figure 1). Therefore, a therapeutic intervention for CAD should be able to influence 
these risk factors.
Blood pressure
Arterial hypertension is associated with an increased incidence of all-cause and cardiovascular mortali-
ty. Especially in survivors of myocardial infarction elevated blood pressure is an independent predictor 
of subsequent morbidity and mortality [4]. Optimal blood pressure is usually achieved by pharmacolo-
gical therapy, but also ET can contribute to blood pressure control. Resting blood pressure, ambulatory 
blood pressure and exercise blood pressure are reduced after regular aerobic exercise training [5]. The-
reby, the improvement in blood pressure decrease seems to be more pronounced in hypertensive than 
in normotensive patients. In different meta-analyses, which included between 29 and 54 randomized 
controlled trials the average in training-mediated decreases of systolic and diastolic blood pressure was 
4.7/3.1 mmHg, 3.4/2.4 mmHg, and 3.8/2.8 mmHg, respectively [6-8].
Blood lipids
Clearly, most patients with CAD are taking li-
pid medications, especially statins, because the 
importance of modifying increased levels of 
low-density lipoprotein cholesterol (LDL) and 
decreased levels of high-density lipoprotein 
cholesterol (HDL) is well established in secon-
dary CAD prevention [9]. Already in 1989, 
Tran et al. performed a meta-analysis including 
15 reports about the effects of ET on lipid and 
lipoprotein levels in patients after myocardial 
infarction. In this study they demonstrated si-
gnificant reductions of total cholesterol, LDL, 
and triglycerides; and an increase in HDL with 
ET [10]. However, most following studies no-
ted reductions in total cholesterol or LDL only 
in the setting of significant exercise-induced 
weight loss [11]. In contrast, effects of ET on 
Figure 1. Causes of endothelial dysfunction 
and their interrelations
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HDL and triglycerides seem to be independent of weight loss [12]. Moreover, Kokkinos et al. reported 
a dose-response relationship between the increase in HDL and miles run per week [13]. More recent 
data suggest the importance of functional properties of HDL beyond pure quantity as therapeutic tar-
get [14]. But so far, the influence of ET on HDL quality is still under investigation.
Glucose intolerance and diabetes mellitus
Diabetes mellitus is the sixth-leading cause of death, with nearly 70% of deaths attributed to car-
diovascular diseases [15]. One of the most important studies on this to-date, a randomized, con-
trolled trial in 251 patients with diabetes mellitus type 2, reported significant changes in absolute 
hemoglobin A1c values of -0.51 percentage point (95% CI: -0.87 to -0.14; p=0.007) after 6 months of 
aerobic training and -0.38 percentage point (CI: -0.72 to -0.22; p=0.038) after 6 months of resistance 
training in comparison to a control group [16]. Moreover, the combination of the two ET modalities 
resulted in an additional change in the hemoglobin A1c value of -0.46 percentage point (CI: -0.83 to 
-0.09; p=0.014) compared with aerobic training alone and -0.59 percentage point (CI: -0.95 to -0.23; 
p=0.001) compared with resistance training alone. In a meta-analysis of Snowling and Hopkins the 
overall beneficial effect of ET on hemoglobin A1c levels was an absolute reduction of −0.8% (90% CI: 
−1.3 to −0.2) [17]. However, these changes are similar to what is seen in an intensive pharmaceutical 
intervention. And even these small improvements have been reported to be clinically significant in 
terms of the effects on a diabetes-related endpoint (sudden death, death from hyperglycaemia or 
hypoglycaemia, fatal or non-fatal myocardial infarction, angina, heart failure, stroke, renal failure, 
amputation (of at least one digit), vitreous haemorrhage, retinal photocoagulation, blindness in one 
eye, or cataract extraction) [18].
Potential mechanisms for a better glucose control due to regular physical ET include improved insulin 
sensitivity/resistance, effects on glucose transporters (eg. GLUT4), muscle hypertrophy and increased 
peripheral blood flow [19-23].
Obesity
Obesity is an independent risk factor for the development of CAD [24]. Moreover, obesity increases 
the risk for CAD indirectly through its association with insulin resistance, unfavourable lipid profi-
les, and hypertension [25]. Although there is an ongoing discussion about the “obesity paradox” in 
patients with CAD and other cardiovascular disorders (in which overweight and obese patients with 
established cardiovascular diseases seem to have better prognosis than do leaner patients), many 
studies have demonstrated the efficacy and safety of weight loss for CAD patients [26-30]. In a large 
study by Lavie et al. a purposeful weight loss and ET program in overweight/obese CAD patients 
was associated with significant improvements in obesity indices, exercise capacity, plasma lipids, and 
inflammation, as well as behavioral factors and quality of life. Moreover, a non-significant trend for 
lower mortality was detectable [29]. In a recent study by Sierra-Johnson et al. weight loss in cardiac 
rehabilitation led to a lower rate of mortality plus acute cardiovascular events, regardless of initial 
BMI [31].
Smoking
Cigarette smoking is a well established major risk factor for CAD, particularly sudden cardiac death. 
Due to a lack of sufficient trials there is no evidence that ET is able to help people quit smoking. So far, 
just one study showed a long-term benefit for ET versus control on abstinence of borderline significan-
ce after 12 months [32]. Most other trials were too small or included an exercise intervention which 
was insufficiently intense to achieve the desired level of exercise. Although a review by Ussher et al. 
support recommendation of ET as an aid for reducing tobacco withdrawal and cravings [33], there is 
no sufficient evidence to recommend exercise as a specific aid to smoking cessation.
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Impact of ET on CAD morbidity and mortality
CAD with preserved left ventricular ejection fraction
Beside above mentioned positive effects of ET on CAD risk factors the most important question for 
our patients is: “Does ET reduce my risk for myocardial infarction or progression of CAD?”. Several 
observational studies have reviewed the relation between participation in a cardiac rehabilitation (CR) 
program and the cardiovascular (CV) prognosis in post-myocardial infarction, post-coronary inter-
vention, and elderly CAD patients [34-38]. Witt et al. examined the association between participation 
in a CR program and survival in 1,821 patients with incident myocardial infarction. And indeed, par-
ticipation in CR was independently associated with improved survival (RR: 0.44; 95% CI: 0.36 to 0.54; 
p<0.001) and decreased risk for recurrent myocardial infarction (RR: 0.72, CI: 0.52 to 0.99, p=0.049) 
[34]. In another study an inverse dose-response relationship between the number of CR sessions and 
long-term outcomes was observed. Attending all recommended 36 sessions was associated with lo-
wer risks of death and myocardial infarction at 4 years compared with attending fewer sessions [35]. 
Likewise, CR completers with CAD have lower risk of death (HR: 0.59; 95% CI: 0.49-0.70), all-cause 
hospitalization (HR: 0.77; 95% CI: 0.71-0.84) and cardiac hospitalization (HR: 0.68; 95% CI: 0.55-0.83) 
in comparison to non-completers with CAD [36]. One of the largest studies with 601,099 U.S. Medicare 
beneficiaries (age ≥ 65 years) who were hospitalized for coronary conditions or cardiac revasculariza-
tion procedures revealed a 21 to 34% lower mortality rate in CR users compared to non-users [38].
Moreover, there have been prospective randomized trials regarding ET in CAD patients. Hambrecht et 
al. compared PCI with a 12-months program of regular physical exercise in patients with stable coro-
nary artery disease [39]. And indeed ET was associated with a higher event-free survival (88% versus 
70% in the PCI group, p=0.023), notably owing to reduced re-hospitalizations and repeat revasculari-
zations. These data are in accordance with the ETICA trial [40]. In this study 118 consecutive patients 
with CAD who underwent percutaneous intervention were randomized into an ET or control group 
for six months. At 33-months follow up patients of the ET group showed a significantly better cardiac 
event-free survival than patients in the non-exercise group.
One of the largest meta-analysis (48 trials with a total of 8,940 patients) regarding effects of ET on 
CAD morbidity and mortality was published by Taylor et al. [41]. They showed that exercise-based 
cardiac rehabilitation reduces both cardiac and total mortality but not the risk of recurrent myocardial 
infarction or revascularization. Moreover, the mortality effects of an ET therapy were consistent across 
a number of coronary heart disease groups (e.g., post-myocardial infarction, post-revascularization, 
angina). A subsequent meta-analysis was focused on the issue how much of the reduction in cardiac 
mortality in coronary heart disease patients with ET is the result of direct effects on the heart and 
coronary vasculature, or to indirect effects, via primary risk factors [42]. And indeed, approximately 
half of the 28% reduction in cardiac mortality achieved with exercise-based cardiac rehabilitation was 
attributable to reductions in major risk factors.
However, for our patients it doesn’t matter if the positive impact of ET is driven by direct effects on the 
heart and coronary vasculature, or indirect effects. It is clear, that ET/physical activity reduces CAD 
mortality and morbidity in addition to dietary, pharmacological and interventional treatments.
CAD with reduced left ventricular ejection fraction
Patients with chronic heart failure (CHF) on basis of CAD are not only limited by a reduced left ven-
tricular (LV) function. Several peripheral maladaptations involving an impaired peripheral perfusion 
secondary to endothelial dysfunction, intrinsic alterations of skeletal muscle, neurohumoral activation 
and impaired endogenous regenerative capacity are evident in the syndrome of CHF [43-46]. Regar-
ding effects of ET on LV remodeling and LV ejection fraction (LVEF) so far published data are hete-
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rogeneous and conflicting. Some studies were able to show an improved LVEF whereas other studies 
did not find changes in LV performance [47-51]. In a meta-analysis of Kaykowsky et al. aerobic but 
not combined aerobic and strength training was associated with improved LVEF as well as reduced LV 
end-diastolic and end-systolic volumes. In contrast to LV performance, several studies were able to 
demonstrate more homogeneous positive effects of regular physical ET on above mentioned peripheral 
alterations in both patients with stable CHF and patients with advanced CHF (NYHA IIIb) [52-55]. 
Moreover, the Exercise training meta-analysis of trials in patients with chronic heart failure (ExTra-
MATCH) showed a significant reduction in the primary endpoint of mortality (HR: 0.65; 95% CI: 
0.46-0.92, p<0.05) and in the secondary endpoint of death or hospitalization (HR: 0.72, 95% CI: 0.56-
0.93, p=0.011) [56]. However, in a recent large randomized clinical trial (HF-ACTION) ET resulted in 
a non-significant reduction in the primary end point of all-cause mortality or hospitalization [57]. But 
after adjustment for highly prognostic predictors the primary end point became modest significant. 
This unexpected result may be attributable to an only modest training intensity and a low adherence 
rate to the ET program in the training group.
Mechanisms
Analysing the underlying mechanisms by which ET exerts its beneficial effects, the following adapta-
tions were reported as possible key players:
1. Correction of generalized endothelial dysfunction;
2. Improvement of endogenous regenerative capacity;
3. Other pathways or mechanisms directly affecting the heart and its blood supply like the training-
induced regression of atherosclerotic lesions or the formation of collaterals.
Correction of generalized endothelial dysfunction
Endothelial dysfunction can occur years before a makroangiopathy, e.g. CAD, becomes evident and 
has been identified as a general phenomenon independently predicting future cardiovascular events 
in patients with cardiovascular diseases or risk factors [58]. Suwaidi et al. measured endothelial fun-
ction in the coronary vessel of 157 patients with moderate non-stenotic CAD and showed significantly 
increased cardiac events (myocardial infarction, percutaneous or surgical coronary revascularization, 
and/or cardiac death) in patients with severe endothelial dysfunction after an average follow up of 28 
months [59]. Schächinger et al. found that impaired endothelial-dependent and endothelium-inde-
pendent coronary vasoreactivity was associated with a significantly higher incidence of cardiovascular 
events over a 7.7-year period [60]. Moreover, impaired peripheral endothelial function independently 
predicts higher rates of in-stent re-stenosis and re-intervention following percutaneous coronary inter-
vention [61]. The first prospective clinical trial, investigating the effect of ET on endothelium-depen-
dent vasodilatation of coronary conduit and resistance vessels was published by Hambrecht et. al. [62]. 
Nineteen patients with coronary endothelial dysfunction, as documented by acetylcholine-induced 
coronary vasoconstriction, were prospectively randomized to a training group or a control group. After 
four weeks of intensive physical ET, acetylcholine-induced coronary artery constriction was significan-
tly reduced by 54%. Coronary flow velocity increased by 142% in the target vessel during acetylcholine 
infusion, indicating a remarkable improvement of acetylcholine-induced endothelial nitric oxide re-
lease. Moreover, coronary flow reserve as an indicator of intra-myocardial resistance vessel function 
increased by 29% after four weeks of ET, whereas it remained virtually unchanged in the control group.
But how can the above mentioned clinical observations and functional changes can be explained on 
the molecular level? In patients with CAD risk factors and cardiovascular diseases, coronary and pe-
ripheral endothelial dysfunction develops secondary to a reduced nitric oxide (NO) production and 
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early NO inactivation by reactive oxygen species (ROS), which are produced in excessive amounts [63]. 
The restoration of the equilibrium between NO production and inactivation by ROS appears to be the 
primary mechanism contributing to the exercise training-mediated improvement in perfusion in CAD. 
Human, animal and cell culture experiments suggest that a repetitive increase in shear stress during ET 
lead to an up-regulation of the endothelial nitric oxide synthase (eNOS), the main source of NO, due 
to a complex pattern of intracellular regulation like acetylation, phosphorylation, and translocation to 
the caveolae [64-69]. In addition, ET has an impact on the generation of ROS, scavenging NO. Exten-
ded periods of ET result in a reduced expression of NAD(P)H oxidase, the major source of ROS, and 
a stimulation of radical scavenging systems like copper-zinc containing superoxide dismutase (SOD), 
extracellular SOD, glutathione peroxidase, and glutathione levels [70-76].
Improvement of endogenous regenerative capacity
In patients with cardiovascular diseases an impaired NO synthesis in association with an increase in 
oxidative stress promotes the loss of endothelial cells by apoptosis and consequently harms the integri-
ty of the vasculature. Additionally, during aging a proportion of endothelial cells lining the vasculature 
is lost, also due to apoptosis [77]. In the past, it was believed that the outgrowth of neighboring endo-
thelial and smooth muscle cells represents the only way of repair in case of vascular damage. Recent 
data provide strong evidence that a subpopulation of bone marrow-derived stem cells – so-called en-
dothelial progenitor cells (EPCs) – are able to promote vascular repair and the formation of entirely 
new vessels through “vasculogenesis” [78,79]. But in patients with atherosclerosis or cardiovascular 
risk factors, repair of endothelial damage by progenitor cells appears to be attenuated [80,81]. Beside an 
absolute reduction in number of EPCs, proliferation, migration and differentiation of EPCs were found 
to be attenuated in patients with atherosclerotic diseases, which is suggestive of an impaired regenera-
tive capacity [80]. The underlying mechanisms contributing to EPC dysfunction and the reduction in 
EPC number in atherosclerotic diseases are not well defined yet. It has been proposed that continuous 
vascular damage in patients with cardiovascular risk factors contributes to an exhaustion of competent 
EPCs in the blood and the bone marrow [82]. Alternatively, an impaired mobilization of EPCs from the 
bone marrow might account for the limited EPCs-derived regenerative capacity.
Animal studies suggest that regular physical activity considerably increases the number of EPCs, since 
ET enhances the NO-mediated liberation from the bone-marrow and reduces the apoptosis of circula-
ting EPCs. These EPCs enhance neoangiogenesis and attenuate neointima formation after vascular in-
jury in exercise-trained animals [83]. The hypothesis of an exercise training-mediated increase in EPCs 
is supported by studies in humans, showing a 4-fold higher number of circulating EPCs in runners 
than in inactive healthy control subjects [84]. However, only little is known about the effects of ET on 
EPC release in patients with CAD and the existing data turned out to be controversial [83,85,86]. Laufs 
et al. reported that ET results in an increase in circulating EPCs in a mouse model and also in patients 
with CAD. At least in mice, this effect was NO-mediated [83]. In contrast, in a study by Sandri et. al, 
EPC levels were found to be unaltered in patients with CAD despite of the fact that the applied training 
below the ischemic threshold increased vascular NO synthesis. Nevertheless, the integrative capacity 
of EPCs was significantly improved as a result of the training intervention that might be involved in 
the regeneration of damaged endothelium [86]. However, when patients with CAD were subjected 
to one single bout of exercise that induced myocardial ischemia a significant increase in the amount 
of circulating EPC was detectable within 24 to 48 hours preceded by a rise in VEGF [85]. These data 
suggest that an enhanced exercise-mediated eNOS expression and NO production – in the absence of 
an ischemic stimulus – do not necessarily affect the number of circulating EPCs in humans. One might 
speculate that the exercise training-mediated modulation of EPC function, possibly in combination 
with an increase in circulating EPC count, rejuvenates the damaged endothelium of the coronary circu-
lation thereby improving myocardial perfusion, but further studies are necessary to address this issue.
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Regression of coronary stenosis and collateral formation
For a long time, it was believed that the training-mediated reduction in risk profile and correction 
of endothelial dysfunction might be associated with a regression of coronary stenosis. However, the 
exercise training-induced regression of coronary atherosclerosis was negligible in the majority of the 
trials and, therefore, most likely does not account for the relief in symptoms and the improvement of 
myocardial perfusion in patients with CAD undergoing exercise training [87-89]. Beside the regres-
sion of atherosclerosis, the formation of collaterals has been considered a mechanism explaining the 
increase in myocardial perfusion in response to ET in CAD. This anticipation was supported by animal 
studies, showing an enhanced exercise training-induced growth of collaterals, in particular in dogs 
[90]. However, studies in humans revealed conflicting results. The Heidelberg Regression Study failed 
to document collateral formation as determined by angiography after one year of regular physical ac-
tivity in patients with significant CAD [91]. Due to the limitations of angiographic evaluation of coro-
nary collaterals Belardinelli et al. used thallium uptake and reported a significant increase of collateral 
coronary blood flow in patients with ischemic cardiomyopathy after ET [92]. However, to clarify the 
importance of coronary collateral formation as a consequence of ET, we have to await the results of the 
upcoming EXCITE trial investigating the effects of intense physical activity on coronary collateral flow 
in patients with CAD [93].
Exercise program for patients with CAD
Upon the recommendation of current guidelines for primary and secondary prevention of cardiova-
scular diseases (CVD) all age groups should perform aerobic exercise, preferably for 30-60 minutes, 
5-7 times a week [1,94,95]. These recommendations also point out that activities to increase muscular 
health and endurance, such as strengthening and flexibility exercises, and balance training to prevent 
falls are important.
Aerobic exercise
In general, regular aerobic physical activity, at intensity levels ranging between 40-85% of maximal 
oxygen consumption (VO2) or heart rate reserve, leads to an improved exercise performance, which 
depends on an increased ability to use oxygen to derive energy for work [96].
Aerobic physical activity in patients with known CAD is usually included into CR program. As already 
mentioned above, a lot of observational studies have been published regarding the relation between 
participation in a CR program and the CV prognosis in post-myocardial infarction, post-coronary in-
tervention, and elderly CAD patients showing in particular an inverse dose-response relation between 
session attendance and mortality/cardiovascular risk [34-38].
In patients with CAD, exercise prescription needs to be tailored to the individual profile after adequate 
exercise-related risk stratification [1]. The most common modes of aerobic exercise include walking, 
jogging, cycling, swimming, rowing, stair climbing, or treadmill. Many approaches may be used to 
determine aerobic exercise intensity [97]. They include % of peak heart rate, heart rate reserve, or the 
Borg Perceived Exertion Scale. The most accurate assessment uses data derived from cardiopulmonary 
exercise test results, in which exercise intensity is determined by measuring the maximal oxygen con-
sumption or the anaerobic threshold. An incremental cardiopulmonary exercise test is proposed as the 
gold standard for a physiologically comprehensive exercise intensity assessment and prescription [98].
In general, low-risk patients, e.g. after uncomplicated MI, should exercise with moderate to vigorous 
intensity for 3-5 sessions per week, each about 30 minutes [1]. Regardless of the total duration of aero-
bic exercise, each session should include a 5-minute warm up to decrease the risk of musculoskeletal 
or cardiovascular complications, and should be finished by a cool down to return heart rate and blood 
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pressure to near pre-exercise values [97]. In severely deconditioned individuals, accumulated bouts of 
exercises for 10 minutes can produce similar benefits than described for longer exercise sessions [99]. 
This finding may support the guideline’s statement that some physical activity is better than none [100].
However, there is an on-going debate about the best way of aerobic exercise in CAD patients which 
can be either continuous or in intervals. Interval ET includes short periods of aerobic exercise at high 
intensity followed by intervals of low intensity. A recent meta-analysis revealed that this mode of ET 
is superior to continuous ET in improving aerobic capacity in patients with CAD [101]. Interval ET 
was shown to improve cardiorespiratory fitness, endothelial function, left ventricle morphology and 
function (e.g. ejection fraction) to a significantly greater extent when compared with conventional 
moderate-intensity continuous training. Although this review provides support for interval training, 
one should be extremely cautious. All reviewed trials are suffered from methodological limitations ac-
cording to the current standards of reporting. The number of examined patients in each trial was small 
and selection of patients could be biased by choosing the fittest ones [101].
Resistance exercise
Strengthening exercises and resistance training improve muscle strength, bone density, coordination, 
balance, and metabolic parameters and thereby lead to a better quality of life and less frailty [102-104]. 
Adequate technique while performing resistance training using hand weights, elastic bands, weight ma-
chines or the person’s own body weight is essential to reduce the risk of injuries. Valsalva manoeuvres 
during resistance exercise should be avoided to reduce the risk of uncontrolled blood pressure elevation 
[102]. The intensity of resistance training can be prescribed by measuring one repetition performed at 
maximal weight, the so called 1 RM. For initial training, 30-60% of 1 RM should be used performing one 
to three sets with 8-15 repetitions with the last repetition producing volitional fatigue. If muscle endu-
rance is the objective, then 30-50% of 1 RM with 15-30 repetitions is considered. For significant strength 
gain, it is recommended to use 50-70% of 1 RM with 8-15 repetitions [97]. Two or three sessions per 
week, interrupted by a rest time of at least 48 hours to allow muscle recovery, are endorsed.
Combination of aerobic and resistance exercise training
The combination of both above described exercise modalities was examined in both CAD and CHF pa-
tients [105,106]. In post-myocardial infarction patients, the combination of endurance and resistance 
exercise is safe without a pronounced left ventricular remodelling in comparison to endurance exercise 
alone. Peak VO2 and muscle strength increased significantly in both groups, but no difference between 
the groups was noticed [105]. Also in CHF, no safety concerns occurred and, in contrast to the before 
mentioned study, the combination of endurance and resistance training had a more pronounced effect 
on submaximal exercise capacity, muscle strength, and quality of life as endurance training alone in 
those patients [106]. But caution is necessary since the studies are small and underpowered. In this 
regard it is important to realize that, in particular in CHF patients, endurance exercise remains the 
mainstay and that resistance exercise or the combination of both can reasonably complement but not 
substitute [107].
Hospital-based vs. home-based secondary prevention programs
Programs provided in hospital settings are well established and use multidisciplinary health care te-
ams to address the main modifiable risk factors [108]. But patients’ attendance to them is low (~30%) 
and is even lower in patients with a greater need for risk reduction [109]. For this reason home-based 
programs have become more common and may be more accessible or preferable to some patients. A 
recent meta-analysis of 36 trials evaluated the benefits and costs of such a home-based secondary pre-
vention program in CAD patients [110]. Clark et al. showed that home-based interventions improved 
the main CV risk factors and quality of life in comparison to usual care. Compared with usual care, 
home-based interventions improved quality of life (weighted mean difference: 0.23; 95% CI: 0.02-0.45), 
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systolic blood pressure (weighted mean difference: -4.36 mmHg; 95% CI: -6.50 to -2.22), smoking 
cessation (difference in proportion: 14%; 95% CI: 0.02-0.26), and total cholesterol (standardized mean 
difference: -0.33; 95% CI: -0.57 to -0.08). But effect sizes were small-to-moderate and the quality of the 
included trials was only low-to-moderate with high levels of heterogeneity. This was one reason why a 
robust comparison between hospital-based and home-based interventions was not possible. In the end, 
the authors conclude that a home-based program may offer a cost effective alternative for stable indi-
viduals less likely to access hospital-based cardiac rehabilitation (e.g. increased distance of residency 
from a cardiac rehabilitation center). Further high quality randomized trials have to clarify the relative 
effectiveness of home-based programs compared to the classical hospital-based CR programs.
Risk of exercise in CVD patients
In patients with an established cardiovascular disease, exercise is intensely determined by exercise re-
lated risk. Different risk stratification algorithms are available [111], and the safety of medically su-
pervised programs is established [1]. The incidence of cardiovascular events while exercising in a CR 
program is low, even in long term exercise programs [112]. Major cardiovascular events may occur from 
1 in 50,000 to 1 in 120,000 patient-hours of exercise. Fatal events are by far rare with 1 in 340,000 to 1 in 
750,000 patient-hours of exercise [113,114]. It is true that a vigorous bout of exercise may increase the 
risk of a CV event by 2- or 3-fold for about 30-60 minutes following the bout, even in adopted exercisers. 
It is reported that ET induces a hypercoagulable state simultaneously with an increase in fibrinolytic 
capacity, especially during short-term strenuous exercise [115]. Conversely to a persistent activation of 
the coagulation cascade, the fibrinolytic activity falls relevantly during the recovery period. Moreover, 
strenuous ET seems to induce a transient increase in platelet counts, aggregation and adhesiveness. The-
se changes in hemostasis and platelet reactivity have been thought to possibly cause acute cardiovascular 
events [115]. However, major cardiovascular events are reduced by 30% to 50% for the continuing 23-
23.5 hours after ET, making the net effect of regular exercise obviously beneficial [116].
What is in the guidelines?
In relation to the before mentioned, both European and American guidelines for CVD prevention, 
describe recommendations for physical activity and CR participation in the means of primary and se-
condary prevention in independent sections [1,95]. Both primary and secondary prevention have the 
Recommendations Level of evidence
ESC Patients with previous acute myocardial infarction, CABG, PCO, stable angina pectoris, 
or should undergo moderate-to-vigorous intensity aerobic exercise training ≥ 3 times 
a week and a 30 min. per session. Sedentary patients should be strongly encouraged 
to start light-intensity exercise programmes after adequate exercise-related risk 
stratification (Class I)
A
AHA/ACCF For all patients, the clinician should encourage 30 to 60 minutes of moderate-intensity 
aerobic activity, such as brisk walking, at least 5 days and preferably 7 days per week, 
supplemented by an increased in daily lifestyle activities (e.g., walking breaks at work, 
gardening, household work) to improve cardiorespiratory fitness and move patients out 
of the least fit, least active high-risk-cohort (bottom 20%) (Class II)
B
Table I. Comparison of recommendations and level of evidence in ESC (European Society 
of Cardiology) and AHA/ACCF (American Heart Association/American College of Cardiology 
Foundation) guidelines [1,95]
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highest recommendation class (I) and level of evidence (A) in the European guidelines whereas the 
level of evidence is medium (B) in the American guidelines (Table I) [1,95]. Furthermore, the Ameri-
can guidelines recommend that it is reasonable for the clinician to recommend complementary resi-
stance training at least 2 days per week (Class IIa, Level of Evidence C) [95]. Absolute contraindications 
are not mentioned but both guidelines emphasize adequate exercise-related risk stratification as discus-
sed above [111].
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